Humanwell Puracap was informed recently by the National Intellectual Property Administration that two patents we applied were granted. Thanks to Mr. Qin Jubo, as well as other colleagues from the R&D department, we filed four patent applications in 2014. During this period, the National Intellectual Property Administration released two rounds of auditing opinions to our company. Working staff of Tsingyihua Intellectual Property LLC gave their reasonable feedback after the repetitive communication with R&D colleagues. Finally, our company obtained two patents successfully, namely, “Method of taking advantage of HPLC to analyze the Amide-plus softgel (Patent No. 20140379846.0” and “Method of taking advantage of High Performance Liquid to analyze the Aminomethamine II softgel” (Patent No. 201410379670.9).  

With the increasing importance of innovation in international competition, Humanwell Puracap will continue to put special attention to the investment in patents and intellectual property rights and the commercialization of our research findings, strive to obtain the initiative in the development of softgel technology related fields and step forward for the goal of becoming a first-class pharmaceutical enterprise in the world.